United States · FDA National Drug Code directory
EPOPROSTENOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67457-588_2a163b77-9e01-4516-b19c-f5a12ce48560
- Product NDC
- 67457-588
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- EPOPROSTENOL
- Labeler
- Mylan Institutional LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240925
- Source listing expiry
- 20261231
Source-listed ingredients
- EPOPROSTENOL — 1.5 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (67457-588-10) / 10 mL in 1 VIAL · 67457-588-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →